We are live on ! Find out more
SYRS icon

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$42.4M +$2.73K +45 +0%
ARK Investment Management
2
ARK Investment Management
Florida
$35.1M +$7.54M +124,308 +32%
Nikko Asset Management Americas
3
Nikko Asset Management Americas
New York
$34.4M +$2.07M +34,089 +7%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$34.4M +$2.07M +34,089 +7%
AVM
5
Arch Venture Management
Illinois
$22.9M -$3.28M -54,123 -14%
FP
6
Flagship Pioneering
Massachusetts
$20.3M – – –
BlackRock
7
BlackRock
New York
$19.8M +$720K +11,865 +4%
Vanguard Group
8
Vanguard Group
Pennsylvania
$12.4M +$8.55K +141 +0.1%
SB
9
Samsara BioCapital
California
$11.3M – – –
Deerfield Management
10
Deerfield Management
New York
$8.77M – – –
JP Morgan Chase
11
JP Morgan Chase
New York
$6.54M +$3.19M +52,550 +125%
BBA
12
Baker Bros. Advisors
New York
$4.77M -$1.73M -28,467 -29%
State Street
13
State Street
Massachusetts
$4.72M +$52.8K +870 +1%
Millennium Management
14
Millennium Management
New York
$3.63M +$3.07M +50,681 +2,699%
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$3.47M +$163K +2,691 +6%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.29M +$146K +2,412 +5%
SCM
17
Sio Capital Management
New York
$3.1M +$2.72M +44,853 New
Northern Trust
18
Northern Trust
Illinois
$2.77M -$154K -2,535 -6%
PCM
19
Portolan Capital Management
Massachusetts
$2.26M +$1.98M +32,685 New
RG
20
Redmile Group
California
$1.47M -$22.3M -367,646 -95%
Charles Schwab
21
Charles Schwab
California
$1.42M +$38K +626 +3%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$1.02M +$450K +7,414 +102%
Nuveen
23
Nuveen
North Carolina
$972K +$200K +3,299 +31%
Renaissance Technologies
24
Renaissance Technologies
New York
$892K -$955K -15,751 -55%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$770K -$667 -11 -0.1%